Standout Papers

Dose-Ranging Effect of Adjunctive Oral Cannabidiol vs Placebo on Convulsive Seizure Frequency in Dravet Syndr... 2020 2026 2022 2024179
  1. Dose-Ranging Effect of Adjunctive Oral Cannabidiol vs Placebo on Convulsive Seizure Frequency in Dravet Syndrome (2020)
    Ian Miller, Ingrid E. Scheffer et al. JAMA Neurology

Immediate Impact

1 from Science/Nature 51 standout
Sub-graph 1 of 23

Citing Papers

New epilepsy therapies in development
2024 Standout
The Role of Glutamate Receptors in Epilepsy
2023 Standout
14 intermediate papers

Works of Rocío Sánchez‐Carpintero being referenced

Dose-Ranging Effect of Adjunctive Oral Cannabidiol vs Placebo on Convulsive Seizure Frequency in Dravet Syndrome
2020 Standout
Fenfluramine for Treatment-Resistant Seizures in Patients With Dravet Syndrome Receiving Stiripentol-Inclusive Regimens
2019
and 5 more

Author Peers

Author Last Decade Papers Cites
Rocío Sánchez‐Carpintero 727 337 177 278 61 1.1k
Μ. Scott Perry 754 391 269 308 73 1.2k
Alberto Verrottı 453 295 97 252 51 898
Seth Ness 496 136 420 117 43 1.4k
Jay A. Salpekar 827 498 128 207 41 1.1k
Wojciech Sobaniec 599 439 145 252 95 1.2k
Richard J. Schain 538 352 467 301 51 1.4k
Masanori Takeoka 747 498 443 316 54 1.4k
Claudia Mehler‐Wex 596 234 140 107 48 1.0k
Massimo Piccirilli 567 144 645 208 55 1.3k
Adel Wassef 498 144 128 184 35 1.1k

All Works

Loading papers...

Rankless by CCL
2026